Friedhelm Blobel serves as Executive at SCICLONE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Friedhelm Blobel has executed 207 insider transactions totaling $14.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 22, 2009 involved purchasing 800 shares valued at $1.4K.
Friedhelm Blobel currently holds 387,299 shares of SCICLONE PHARMACEUTICALS INC (SCLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Friedhelm Blobel has been a net seller of SCLN stock. They have purchased $128.2K and sold $14.7M worth of shares.
Friedhelm Blobel's most recent insider trade was on May 22, 2009, when they purchased 800 shares at $1.71 per share.
Get notified when new Form 4 filings are submitted
| $1.71 |
| Discretionary |
| May 20, 2008 | SCLN | $4.3K | Purchase | 2,500 | $1.70 | Discretionary |
| May 20, 2008 | SCLN | $4.3K | Purchase | 2,500 | $1.70 | Discretionary |
| May 19, 2008 | SCLN | $7.0K | Purchase | 4,000 | $1.75 | Discretionary |
| May 19, 2008 | SCLN | $1.7K | Purchase | 1,000 | $1.74 | Discretionary |
| Nov 20, 2007 | SCLN | $9.7K | Purchase | 5,000 | $1.93 | Discretionary |